The scene of therapeutics for Niemann-Pick Disease Type C (NPC) is a rapidly changing one, with significant strides being made in research. Several promising therapeutic methods are currently experiencing clinical trials, offering hope for sufferers living with this uncommon and deteriorating neurodegenerative disorder. A mixture of drug-driven th